- Home
- Publications
- Publication Search
- Publication Details
Title
Polyglutamine diseases
Authors
Keywords
Polyglutamine, Repeat expansion, CAG repeat, Huntington’s disease, Spinal and bulbar muscular atrophy, Spinocerebellar ataxias
Journal
CURRENT OPINION IN NEUROBIOLOGY
Volume 72, Issue -, Pages 39-47
Publisher
Elsevier BV
Online
2021-09-03
DOI
10.1016/j.conb.2021.07.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulation of ATXN1 S776 phosphorylation reveals the importance of allele-specific targeting in SCA1
- (2021) Larissa Nitschke et al. JCI Insight
- Staufen1 in Human Neurodegeneration
- (2021) Sharan Paul et al. ANNALS OF NEUROLOGY
- On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability
- (2020) Alexandra N. Khristich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17
- (2020) Qiong Liu et al. Nature Communications
- Staufen 1 amplifies proapoptotic activation of the unfolded protein response
- (2020) Mandi Gandelman et al. CELL DEATH AND DIFFERENTIATION
- ALS-associated genes in SCA2 mouse spinal cord transcriptomes
- (2020) Daniel R Scoles et al. HUMAN MOLECULAR GENETICS
- Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form
- (2020) Huiming Yang et al. Nature Communications
- Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier Effects
- (2020) Kyung-Hee Kim et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel–Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3
- (2020) David D. Bushart et al. CEREBELLUM
- Molecular pathogenesis of spinal bulbar muscular atrophy (Kennedy's disease) and avenues for treatment
- (2020) Christopher Grunseich et al. CURRENT OPINION IN NEUROLOGY
- miR760 regulates ATXN1 levels via interaction with its 5′ untranslated region
- (2020) Larissa Nitschke et al. GENES & DEVELOPMENT
- Patterns of CAG repeat instability in the central nervous system and periphery in Huntington’s disease and in spinocerebellar ataxia type 1
- (2020) Ricardo Mouro Pinto et al. HUMAN MOLECULAR GENETICS
- Linking epigenetic dysregulation, mitochondrial impairment, and metabolic dysfunction in SBMA motor neurons
- (2020) Naemeh Pourshafie et al. JCI Insight
- Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1
- (2020) Ravi Chopra et al. HUMAN MOLECULAR GENETICS
- Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington’s disease knock-in mice is blocked by Mlh1 knock-out
- (2020) Jacob M Loupe et al. HUMAN MOLECULAR GENETICS
- Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease
- (2019) Galen E.B. Wright et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Side chain to main chain hydrogen bonds stabilize a polyglutamine helix in a transcription factor
- (2019) Albert Escobedo et al. Nature Communications
- Spinocerebellar ataxia
- (2019) Thomas Klockgether et al. Nature Reviews Disease Primers
- MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1
- (2019) Michael Flower et al. BRAIN
- CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset
- (2019) Jong-Min Lee et al. CELL
- 5′UTR-mediated regulation of Ataxin-1 expression
- (2019) Rachna Manek et al. NEUROBIOLOGY OF DISEASE
- A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes
- (2019) Marc Ciosi et al. EBioMedicine
- Nicotinamide Pathway-Dependent Sirt1 Activation Restores Calcium Homeostasis to Achieve Neuroprotection in Spinocerebellar Ataxia Type 7
- (2019) Colleen A. Stoyas et al. NEURON
- Oligonucleotide therapy mitigates disease in Spinocerebellar Ataxia Type 3 mice
- (2018) Hayley S. McLoughlin et al. ANNALS OF NEUROLOGY
- PAK1 regulates ATXN1 levels providing an opportunity to modify its toxicity in spinocerebellar ataxia type 1
- (2018) Vitaliy V Bondar et al. HUMAN MOLECULAR GENETICS
- Protein kinase C activity is a protective modifier of Purkinje neuron degeneration in cerebellar ataxia
- (2018) Ravi Chopra et al. HUMAN MOLECULAR GENETICS
- Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model
- (2018) Judit M. Pérez Ortiz et al. NEUROBIOLOGY OF DISEASE
- ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism
- (2018) Maxime W.C. Rousseaux et al. NEURON
- Ion channel dysfunction in cerebellar ataxia
- (2018) David D. Bushart et al. NEUROSCIENCE LETTERS
- Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration
- (2018) Sharan Paul et al. Nature Communications
- Regulatory mechanisms of incomplete huntingtin mRNA splicing
- (2018) Andreas Neueder et al. Nature Communications
- Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration
- (2018) Paola Rusmini et al. Autophagy
- FAN1 modifies Huntington’s disease progression by stabilising the expanded HTT CAG repeat
- (2018) Robert Goold et al. HUMAN MOLECULAR GENETICS
- Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7
- (2018) Chenchen Niu et al. Science Translational Medicine
- A modifier of Huntington's disease onset at the MLH1 locus
- (2017) Jong-Min Lee et al. HUMAN MOLECULAR GENETICS
- Potassium channel dysfunction underlies Purkinje neuron spiking abnormalities in spinocerebellar ataxia type 2
- (2017) James M Dell’Orco et al. HUMAN MOLECULAR GENETICS
- Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
- (2017) Davina J Hensman Moss et al. LANCET NEUROLOGY
- Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
- (2017) Daniel R. Scoles et al. NATURE
- Disruption of the ATXN1–CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans
- (2017) Hsiang-Chih Lu et al. NATURE GENETICS
- Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice
- (2017) Lodewijk J.A. Toonen et al. Molecular Therapy-Nucleic Acids
- Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
- (2017) Lauren R. Moore et al. Molecular Therapy-Nucleic Acids
- The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
- (2017) Andreas Neueder et al. Scientific Reports
- DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases
- (2016) Conceição Bettencourt et al. ANNALS OF NEUROLOGY
- Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways
- (2016) Melissa Ingram et al. NEURON
- 4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6
- (2016) Sriram Jayabal et al. Scientific Reports
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now